National Research Corporation
NRC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 8.81 | -1.19 | 0.94 |
| FCF Yield | 3.53% | -1.09% | 1.24% | 0.47% |
| EV / EBITDA | 36.91 | 136.02 | 35.10 | 42.30 |
| Quality | ||||
| ROIC | 5.03% | -0.26% | 6.20% | 6.95% |
| Gross Margin | 57.82% | 56.77% | 56.49% | 61.12% |
| Cash Conversion Ratio | 3.34 | 10.75 | 1.15 | 0.97 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.20% | -1.87% | -1.89% | -1.91% |
| Free Cash Flow Growth | 345.24% | -213.36% | 89.15% | -75.27% |
| Safety | ||||
| Net Debt / EBITDA | 7.84 | 22.56 | 6.17 | 5.26 |
| Interest Coverage | 5.30 | 1.54 | 9.56 | 13.15 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 2.37 | -7.34 | 18.25 | 19.81 |